Aimmune Therapeutics Announces Phase 2 Extended Maintenance Data Supporting Safety and Tolerability Profile of AR101 for Peanut Allergy by mariel | Jun 13, 2016 | Portfolio News
Corcept Therapeutics Provides Update of Progress in Cortisol Modulation Oncology Program by mariel | Jun 2, 2016 | Portfolio News
Jazz Pharmaceuticals And Celator Pharmaceuticals Announce Agreement For Jazz Pharmaceuticals To Acquire Celator For $30.25 Per Share by mariel | May 31, 2016 | Portfolio News
